Stratus Medical Secures $10 Million Financing for Innovations
Stratus Medical, a pioneering company dedicated to enhancing radiofrequency (RF) ablation technology for chronic pain relief, has successfully secured a $10 million Series B financing. This funding, spearheaded by Wasatch Health Partners, an investment firm specializing in healthcare, underscores the increasing investor confidence in Stratus Medical's mission and technology advancements.
Funding Purpose and Future Prospects
The recent financing will play a critical role in finalizing the development of the Stratus Medical RF Generator, alongside the innovative neurovasis technology for basivertebral nerve ablation (BVNA). Additionally, the funds will aid in extending and safeguarding the company’s extensive patent portfolio and support a vital clinical study. Through these cutting-edge technologies, Stratus Medical aims to better cater to the expanding needs of its clientele and leverage the acclaimed Nimbus RF Multitined Expandable Electrode design.
Understanding Vertebrogenic Low Back Pain
Vertebrogenic low back pain tends to arise when there is damage to the vertebral endplates in the spinal column, often stemming from ongoing degeneration. Patients currently find relief through various treatments including medications and physical therapy, as well as BVNA techniques. Research indicates that over five million individuals in the United States are affected by vertebrogenic back pain, highlighting the urgent need for improved treatment options.
The Technology Behind Stratus Medical
It's important to note that both the Stratus Medical RF Generator and neurovasis BVNA technologies are still in development and have not yet undergone the FDA evaluation or clearance processes.
Luke Larsen, Vice President at Wasatch Health Partners, expressed his enthusiasm regarding the partnership, stating, "We are delighted to further our collaboration with Stratus Medical. Their consistent revenue growth and strong execution indicate a well-positioned management team ready to capitalize on this momentum."
Expert Insights on Progress
Bret Boudousquie, CEO of Stratus Medical, acknowledged the importance of their ongoing relationship with Wasatch Health Partners, emphasizing their shared mission to improve the lives of those suffering from chronic pain through advanced RF technology. He mentioned the commitment to work with exceptional health professionals and institutions, indicating their readiness to enhance their offerings through the additional funding.
Dr. Doug Beall, an expert in Interventional Radiology, shared his experience using Nimbus for radiofrequency ablation since 2020, citing the technology’s benefits and ease of use. He has also contributed to developing the neurovasis project, marking significant strides within the company’s advancements. The potential of this technology not only aims to simplify procedures but also to offer significant cost savings for hospitals and outpatient surgical centers.
About Stratus Medical
Stratus Medical is dedicated to developing medical devices that significantly alleviate pain and enhance the quality of life for chronic pain sufferers through innovation. The company has achieved recognition for its rapid growth and innovative solutions, including accolades from industry leaders. The Nimbus technology has gained traction in the U.S. and beyond, thanks to its simplicity, efficiency, and capacity for providing lasting pain relief. Headquartered in Magnolia, Texas, Stratus Medical continues to strive for excellence in pain management solutions.
About Wasatch Health Partners
Wasatch Health Partners is an investment firm focused on the healthcare sector, targeting opportunities in medical devices, life sciences, and pharmaceutical services through growth equity, middle-market buyouts, and structured capital solutions. The firm operates out of Salt Lake City, Utah, and its investment strategies reflect a commitment to driving innovation in health care.
Frequently Asked Questions
What is the main purpose of the $10 million financing for Stratus Medical?
The funding is aimed at completing the development of the Stratus Medical RF Generator, expanding the patent portfolio, and financing a clinical study.
Who led the Series B financing round for Stratus Medical?
The financing round was led by Wasatch Health Partners, which specializes in healthcare investments.
What are the expected outcomes of the new technologies being developed by Stratus Medical?
The new technologies aim to enhance chronic pain treatments and improve patient outcomes through advanced RF ablation techniques.
How does vertebrogenic low back pain affect individuals?
This condition affects millions and is characterized by pain stemming from damage to vertebral endplates, requiring effective treatment options.
What recognition has Stratus Medical received for its innovations?
Stratus Medical has been acknowledged for its revenue growth and innovation by several prestigious organizations, emphasizing its impact in the medical device industry.
